VT News
Michael Crabtree

Michael Crabtree

Ask VT AI
View News Summary
  • Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
  • Tech giants report mixed earnings amid AI investments and market shifts, as Wall Street remains cautiously optimistic about the sector's future.
  • Mayoral races heat up across the country as candidates clash on key issues like gun control, homelessness, and economic development.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
  • Tech giants report mixed earnings amid AI investments and market shifts, as Wall Street remains cautiously optimistic about the sector's future.
  • Mayoral races heat up across the country as candidates clash on key issues like gun control, homelessness, and economic development.
20 days
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Michael Crabtree

Top Topics

Trending in U.S.

World

Sport